Drugs Repurposed as Antiferroptosis Agents Suppress Organ Damage, Including AKI, by Functioning as Lipid Peroxyl Radical Scavengers.
Eikan MishimaEmiko SatoJunya ItoKen-Ichi YamadaChitose SuzukiYoshitsugu OikawaTetsuro MatsuhashiKoichi KikuchiTakafumi ToyoharaTakehiro SuzukiSadayoshi ItoKiyotaka NakagawaTakaaki K AbePublished in: Journal of the American Society of Nephrology : JASN (2019)
Although elevated lipid peroxyl radical levels can trigger ferroptosis onset, some drugs that scavenge lipid peroxyl radicals can help control ferroptosis-related disorders, including AKI.